May 25, 2022 Financial News EU court to rule July 13 on Illumina challenge of EU review of Grail -sources
Illumina blasts EU antitrust regulators over Grail deal scrutiny By Foo Yun Chee LUXEMBOURG – U.S. life sciences company Illumina on Thursday criticised EU antitrust regulators for scrutinising its $8 billion cash-and-stock takeover of Grail even though the cancer detection test maker has no…